- Home
- LYG vs EW Comparison
LYG vs EW Comparison
Compare LYG & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYG
- EW
- Stock Information
- Founded
- LYG 1695
- EW 1958
- Country
- LYG United Kingdom
- EW United States
- Employees
- LYG N/A
- EW N/A
- Industry
- LYG Commercial Banks
- EW Industrial Specialties
- Sector
- LYG Finance
- EW Health Care
- Exchange
- LYG Nasdaq
- EW Nasdaq
- Market Cap
- LYG 39.8B
- EW 42.5B
- IPO Year
- LYG N/A
- EW 2000
- Fundamental
- Price
- LYG $2.86
- EW $69.78
- Analyst Decision
- LYG Buy
- EW Buy
- Analyst Count
- LYG 4
- EW 21
- Target Price
- LYG $2.75
- EW $78.48
- AVG Volume (30 Days)
- LYG 13.9M
- EW 4.9M
- Earning Date
- LYG 02-20-2025
- EW 02-04-2025
- Dividend Yield
- LYG 5.19%
- EW N/A
- EPS Growth
- LYG N/A
- EW 193.69
- EPS
- LYG 0.09
- EW 6.89
- Revenue
- LYG $24,874,681,670.00
- EW $6,314,900,000.00
- Revenue This Year
- LYG N/A
- EW N/A
- Revenue Next Year
- LYG $5.27
- EW $1.06
- P/E Ratio
- LYG $7.25
- EW $26.91
- Revenue Growth
- LYG 7.75
- EW 24.02
- 52 Week Low
- LYG $2.00
- EW $58.93
- 52 Week High
- LYG $3.24
- EW $96.12
- Technical
- Relative Strength Index (RSI)
- LYG 61.49
- EW 36.55
- Support Level
- LYG $2.56
- EW $68.24
- Resistance Level
- LYG $2.84
- EW $72.10
- Average True Range (ATR)
- LYG 0.05
- EW 1.55
- MACD
- LYG 0.02
- EW -0.66
- Stochastic Oscillator
- LYG 89.39
- EW 19.27
About LYG Lloyds Banking Group Plc
Lloyds is a retail and commercial bank headquartered in the United Kingdom. The bank operates via three business segments: retail, commercial banking, and insurance and wealth. In retail, Lloyds offers primarily mortgages (66% of loan portfolio), credit cards, and current accounts to its customers. Its commercial banking operation provides lending, transaction banking, working capital management, and debt capital market services to large companies and financial institutions in the UK Insurance and wealth rounds out the product lineup with life and property insurance as well as pension solutions and high-net-worth asset-management services.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.